ID   ODBA_HUMAN              Reviewed;         445 AA.
AC   P12694; B4DP47; E7EW46; Q16034; Q16472;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   12-APR-2017, entry version 203.
DE   RecName: Full=2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial;
DE            EC=1.2.4.4;
DE   AltName: Full=Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain;
DE            Short=BCKDE1A;
DE            Short=BCKDH E1-alpha;
DE   Flags: Precursor;
GN   Name=BCKDHA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1420356; DOI=10.1016/0167-4781(92)90149-T;
RA   McKean M.C., Winkeler K.A., Danner D.J.;
RT   "Nucleotide sequence of the 5' end including the initiation codon of
RT   cDNA for the E1 alpha subunit of the human branched chain alpha-
RT   ketoacid dehydrogenase complex.";
RL   Biochim. Biophys. Acta 1171:109-112(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-445 (ISOFORM 1).
RX   PubMed=2914958;
RA   Fisher C.W., Chuang J.L., Griffin T.A., Lau K.S., Cox R.P.,
RA   Chuang D.T.;
RT   "Molecular phenotypes in cultured maple syrup urine disease cells.
RT   Complete E1 alpha cDNA sequence and mRNA and subunit contents of the
RT   human branched chain alpha-keto acid dehydrogenase complex.";
RL   J. Biol. Chem. 264:3448-3453(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-445, AND VARIANT MSUD1A
RP   ASN-438.
RX   PubMed=2060625; DOI=10.1016/0014-5793(91)80755-R;
RA   Dariush N., Fisher C.W., Cox R.P., Chuang D.T.;
RT   "Structure of the gene encoding the entire mature E1 alpha subunit of
RT   human branched-chain alpha-keto acid dehydrogenase complex.";
RL   FEBS Lett. 284:34-38(1991).
RN   [7]
RP   ERRATUM.
RX   PubMed=1682165; DOI=10.1016/0014-5793(91)81324-2;
RA   Dariush N., Fisher C.W., Cox R.P., Chuang D.T.;
RL   FEBS Lett. 291:376-377(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-445 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3224821; DOI=10.1016/0378-1119(88)90390-3;
RA   Zhang B., Crabb D.W., Harris R.A.;
RT   "Nucleotide and deduced amino acid sequence of the E1 alpha subunit of
RT   human liver branched-chain alpha-ketoacid dehydrogenase.";
RL   Gene 69:159-164(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 46-57.
RX   PubMed=7918575; DOI=10.1016/0304-4165(94)90161-9;
RA   Wynn R.M., Kochi H., Cox R.P., Chuang D.T.;
RT   "Differential processing of human and rat E1 alpha precursors of the
RT   branched-chain alpha-keto acid dehydrogenase complex caused by an N-
RT   terminal proline in the rat sequence.";
RL   Biochim. Biophys. Acta 1201:125-128(1994).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 46-445 IN COMPLEX WITH
RP   THIAMINE PYROPHOSPHATE AND POTASSIUM IONS, AND SUBUNIT STRUCTURE.
RX   PubMed=10745006; DOI=10.1016/S0969-2126(00)00105-2;
RA   Aevarsson A., Chuang J.L., Wynn R.M., Turley S., Chuang D.T.,
RA   Hol W.G.J.;
RT   "Crystal structure of human branched-chain alpha-ketoacid
RT   dehydrogenase and the molecular basis of multienzyme complex
RT   deficiency in maple syrup urine disease.";
RL   Structure 8:277-291(2000).
RN   [11]
RP   VARIANT MSUD1A CYS-413.
RX   PubMed=8037208;
RA   Chuang J.L., Fisher C.R., Cox R.P., Chuang D.T.;
RT   "Molecular basis of maple syrup urine disease: novel mutations at the
RT   E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease
RT   steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid
RT   dehydrogenase complex.";
RL   Am. J. Hum. Genet. 55:297-304(1994).
RN   [12]
RP   VARIANT MSUD1A ASN-438.
RX   PubMed=2703538; DOI=10.1172/JCI114033;
RA   Zhang B., Edenberg H.J., Crabb D.W., Harris R.A.;
RT   "Evidence for both a regulatory mutation and a structural mutation in
RT   a family with maple syrup urine disease.";
RL   J. Clin. Invest. 83:1425-1429(1989).
RN   [13]
RP   VARIANT MSUD1A ASN-438.
RX   PubMed=2241958; DOI=10.1016/0006-291X(90)90723-Z;
RA   Matsuda I., Nobukuni Y., Mitsubuchi H., Indo Y., Endo F., Asaka J.,
RA   Harada A.;
RT   "A T-to-A substitution in the E1 alpha subunit gene of the branched-
RT   chain alpha-ketoacid dehydrogenase complex in two cell lines derived
RT   from Menonite maple syrup urine disease patients.";
RL   Biochem. Biophys. Res. Commun. 172:646-651(1990).
RN   [14]
RP   VARIANT MSUD1A ASN-438.
RX   PubMed=1867199;
RA   Fisher C.R., Fisher C.W., Chuang D.T., Cox R.P.;
RT   "Occurrence of a Tyr393-->Asn (Y393N) mutation in the E1 alpha gene of
RT   the branched-chain alpha-keto acid dehydrogenase complex in maple
RT   syrup urine disease patients from a Mennonite population.";
RL   Am. J. Hum. Genet. 49:429-434(1991).
RN   [15]
RP   VARIANT MSUD1A ASN-438.
RX   PubMed=1885764; DOI=10.1172/JCI115363;
RA   Fisher C.R., Chuang J.L., Cox R.P., Fisher C.W., Star R.A.,
RA   Chuang D.T.;
RT   "Maple syrup urine disease in Mennonites. Evidence that the Y393N
RT   mutation in E1 alpha impedes assembly of the E1 component of branched-
RT   chain alpha-keto acid dehydrogenase complex.";
RL   J. Clin. Invest. 88:1034-1037(1991).
RN   [16]
RP   VARIANTS MSUD1A TRP-159; LYS-190; THR-253 AND THR-326.
RX   PubMed=8161368;
RA   Nobukuni Y., Mitsubuchi H., Hayashida Y., Ohta K., Indo Y., Ichiba Y.,
RA   Endo F., Matsuda I.;
RT   "Heterogeneity of mutations in maple syrup urine disease (MSUD):
RT   screening and identification of affected E1 alpha and E1 beta subunits
RT   of the branched-chain alpha-keto-acid dehydrogenase multienzyme
RT   complex.";
RL   Biochim. Biophys. Acta 1225:64-70(1993).
RN   [17]
RP   VARIANTS MSUD1A ARG-290 AND CYS-409.
RX   PubMed=7883996; DOI=10.1172/JCI117804;
RA   Chuang J.L., Davie J.R., Chinsky J.M., Wynn R.M., Cox R.P.,
RA   Chuang D.T.;
RT   "Molecular and biochemical basis of intermediate maple syrup urine
RT   disease: occurrence of homozygous G245R and F364C mutations at the E1-
RT   alpha locus of Hispanic-Mexican patients.";
RL   J. Clin. Invest. 95:954-963(1995).
RN   [18]
RP   VARIANTS MSUD1A MET-211; VAL-220; CYS-346; LYS-PRO-403 INS AND
RP   427-LEU-ALA-428 DELINS PRO.
RX   PubMed=21844576;
RA   Park H.D., Lee D.H., Hong Y.H., Kang D.H., Lee Y.K., Song J.,
RA   Lee S.Y., Kim J.W., Ki C.S., Lee Y.W.;
RT   "Three Korean patients with maple syrup urine disease: four novel
RT   mutations in the BCKDHA gene.";
RL   Ann. Clin. Lab. Sci. 41:167-173(2011).
CC   -!- FUNCTION: The branched-chain alpha-keto dehydrogenase complex
CC       catalyzes the overall conversion of alpha-keto acids to acyl-CoA
CC       and CO(2). It contains multiple copies of three enzymatic
CC       components: branched-chain alpha-keto acid decarboxylase (E1),
CC       lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).
CC   -!- CATALYTIC ACTIVITY: 3-methyl-2-oxobutanoate +
CC       [dihydrolipoyllysine-residue (2-methylpropanoyl)transferase]
CC       lipoyllysine = [dihydrolipoyllysine-residue (2-
CC       methylpropanoyl)transferase] S-(2-
CC       methylpropanoyl)dihydrolipoyllysine + CO(2).
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC   -!- SUBUNIT: Heterotetramer of alpha and beta chains.
CC       {ECO:0000269|PubMed:10745006}.
CC   -!- INTERACTION:
CC       P21953:BCKDHB; NbExp=14; IntAct=EBI-1029053, EBI-1029067;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P12694-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12694-2; Sequence=VSP_056156, VSP_056157;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Maple syrup urine disease 1A (MSUD1A) [MIM:248600]: A
CC       metabolic disorder due to an enzyme defect in the catabolic
CC       pathway of the branched-chain amino acids leucine, isoleucine, and
CC       valine. Accumulation of these 3 amino acids and their
CC       corresponding keto acids leads to encephalopathy and progressive
CC       neurodegeneration. Clinical features include mental and physical
CC       retardation, feeding problems, and a maple syrup odor to the
CC       urine. The keto acids of the branched-chain amino acids are
CC       present in the urine. If untreated, maple syrup urine disease can
CC       lead to seizures, coma, and death. The disease is often classified
CC       by its pattern of signs and symptoms. The most common and severe
CC       form of the disease is the classic type, which becomes apparent
CC       soon after birth. Variant forms of the disorder become apparent
CC       later in infancy or childhood and are typically milder, but they
CC       still involve developmental delay and other medical problems if
CC       not treated. {ECO:0000269|PubMed:1867199,
CC       ECO:0000269|PubMed:1885764, ECO:0000269|PubMed:2060625,
CC       ECO:0000269|PubMed:21844576, ECO:0000269|PubMed:2241958,
CC       ECO:0000269|PubMed:2703538, ECO:0000269|PubMed:7883996,
CC       ECO:0000269|PubMed:8037208, ECO:0000269|PubMed:8161368}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: Bound potassium ions stabilize the protein
CC       structure.
CC   -!- SIMILARITY: Belongs to the BCKDHA family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB59549.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z14093; CAA78475.1; -; mRNA.
DR   EMBL; AK298188; BAG60459.1; -; mRNA.
DR   EMBL; AC011462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007878; AAH07878.1; -; mRNA.
DR   EMBL; BC008933; AAH08933.1; -; mRNA.
DR   EMBL; BC023983; AAH23983.1; -; mRNA.
DR   EMBL; J04474; AAB59549.1; ALT_INIT; mRNA.
DR   EMBL; AH003771; AAB20222.2; -; Genomic_DNA.
DR   EMBL; AH003707; AAB19268.2; -; Genomic_DNA.
DR   EMBL; M22221; AAA35590.1; -; mRNA.
DR   CCDS; CCDS12581.1; -. [P12694-1]
DR   PIR; S27156; DEHUXA.
DR   RefSeq; NP_000700.1; NM_000709.3. [P12694-1]
DR   RefSeq; NP_001158255.1; NM_001164783.1.
DR   UniGene; Hs.433307; -.
DR   PDB; 1DTW; X-ray; 2.70 A; A=46-445.
DR   PDB; 1OLS; X-ray; 1.85 A; A=46-445.
DR   PDB; 1OLU; X-ray; 1.90 A; A=46-445.
DR   PDB; 1OLX; X-ray; 2.25 A; A=46-445.
DR   PDB; 1U5B; X-ray; 1.83 A; A=46-445.
DR   PDB; 1V11; X-ray; 1.95 A; A=46-445.
DR   PDB; 1V16; X-ray; 1.90 A; A=46-445.
DR   PDB; 1V1M; X-ray; 2.00 A; A=46-445.
DR   PDB; 1V1R; X-ray; 1.80 A; A=46-445.
DR   PDB; 1WCI; X-ray; 1.84 A; A=46-445.
DR   PDB; 1X7W; X-ray; 1.73 A; A=46-445.
DR   PDB; 1X7X; X-ray; 2.10 A; A=46-445.
DR   PDB; 1X7Y; X-ray; 1.57 A; A=46-445.
DR   PDB; 1X7Z; X-ray; 1.72 A; A=46-445.
DR   PDB; 1X80; X-ray; 2.00 A; A=46-445.
DR   PDB; 2BEU; X-ray; 1.89 A; A=46-445.
DR   PDB; 2BEV; X-ray; 1.80 A; A=46-445.
DR   PDB; 2BEW; X-ray; 1.79 A; A=46-445.
DR   PDB; 2BFB; X-ray; 1.77 A; A=46-445.
DR   PDB; 2BFC; X-ray; 1.64 A; A=46-445.
DR   PDB; 2BFD; X-ray; 1.39 A; A=46-445.
DR   PDB; 2BFE; X-ray; 1.69 A; A=46-445.
DR   PDB; 2BFF; X-ray; 1.46 A; A=46-445.
DR   PDB; 2J9F; X-ray; 1.88 A; A/C=46-445.
DR   PDBsum; 1DTW; -.
DR   PDBsum; 1OLS; -.
DR   PDBsum; 1OLU; -.
DR   PDBsum; 1OLX; -.
DR   PDBsum; 1U5B; -.
DR   PDBsum; 1V11; -.
DR   PDBsum; 1V16; -.
DR   PDBsum; 1V1M; -.
DR   PDBsum; 1V1R; -.
DR   PDBsum; 1WCI; -.
DR   PDBsum; 1X7W; -.
DR   PDBsum; 1X7X; -.
DR   PDBsum; 1X7Y; -.
DR   PDBsum; 1X7Z; -.
DR   PDBsum; 1X80; -.
DR   PDBsum; 2BEU; -.
DR   PDBsum; 2BEV; -.
DR   PDBsum; 2BEW; -.
DR   PDBsum; 2BFB; -.
DR   PDBsum; 2BFC; -.
DR   PDBsum; 2BFD; -.
DR   PDBsum; 2BFE; -.
DR   PDBsum; 2BFF; -.
DR   PDBsum; 2J9F; -.
DR   ProteinModelPortal; P12694; -.
DR   SMR; P12694; -.
DR   BioGrid; 107065; 24.
DR   DIP; DIP-6146N; -.
DR   IntAct; P12694; 8.
DR   MINT; MINT-271818; -.
DR   STRING; 9606.ENSP00000269980; -.
DR   iPTMnet; P12694; -.
DR   PhosphoSitePlus; P12694; -.
DR   BioMuta; BCKDHA; -.
DR   EPD; P12694; -.
DR   MaxQB; P12694; -.
DR   PaxDb; P12694; -.
DR   PeptideAtlas; P12694; -.
DR   PRIDE; P12694; -.
DR   Ensembl; ENST00000269980; ENSP00000269980; ENSG00000248098. [P12694-1]
DR   Ensembl; ENST00000457836; ENSP00000416000; ENSG00000248098. [P12694-2]
DR   GeneID; 593; -.
DR   KEGG; hsa:593; -.
DR   UCSC; uc002oqq.4; human. [P12694-1]
DR   CTD; 593; -.
DR   DisGeNET; 593; -.
DR   GeneCards; BCKDHA; -.
DR   GeneReviews; BCKDHA; -.
DR   HGNC; HGNC:986; BCKDHA.
DR   HPA; HPA036640; -.
DR   MalaCards; BCKDHA; -.
DR   MIM; 248600; phenotype.
DR   MIM; 608348; gene.
DR   neXtProt; NX_P12694; -.
DR   OpenTargets; ENSG00000248098; -.
DR   Orphanet; 268145; Classic maple syrup urine disease.
DR   Orphanet; 268162; Intermediate maple syrup urine disease.
DR   Orphanet; 268173; Intermittent maple syrup urine disease.
DR   Orphanet; 268184; Thiamine-responsive maple syrup urine disease.
DR   PharmGKB; PA25297; -.
DR   eggNOG; KOG1182; Eukaryota.
DR   eggNOG; COG1071; LUCA.
DR   GeneTree; ENSGT00530000063174; -.
DR   HOGENOM; HOG000281337; -.
DR   HOVERGEN; HBG002459; -.
DR   InParanoid; P12694; -.
DR   KO; K00166; -.
DR   OrthoDB; EOG091G073F; -.
DR   PhylomeDB; P12694; -.
DR   TreeFam; TF300863; -.
DR   BioCyc; MetaCyc:MONOMER-12005; -.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; P12694; -.
DR   SIGNOR; P12694; -.
DR   EvolutionaryTrace; P12694; -.
DR   GeneWiki; BCKDHA; -.
DR   GenomeRNAi; 593; -.
DR   PRO; PR:P12694; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000248098; -.
DR   CleanEx; HS_BCKDHA; -.
DR   ExpressionAtlas; P12694; baseline and differential.
DR   Genevisible; P12694; HS.
DR   GO; GO:0005947; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; IDA:HGNC.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0003863; F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; TAS:ProtInc.
DR   GO; GO:0003826; F:alpha-ketoacid dehydrogenase activity; IDA:HGNC.
DR   GO; GO:0016831; F:carboxy-lyase activity; TAS:HGNC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; IDA:HGNC.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   InterPro; IPR034616; BCKDH_E1-a.
DR   InterPro; IPR001017; DH_E1.
DR   InterPro; IPR029061; THDP-binding.
DR   PANTHER; PTHR43380:SF1; PTHR43380:SF1; 1.
DR   Pfam; PF00676; E1_dh; 1.
DR   SUPFAM; SSF52518; SSF52518; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation;
KW   Maple syrup urine disease; Metal-binding; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Potassium;
KW   Reference proteome; Thiamine pyrophosphate; Transit peptide.
FT   TRANSIT       1     45       Mitochondrion.
FT                                {ECO:0000269|PubMed:7918575}.
FT   CHAIN        46    445       2-oxoisovalerate dehydrogenase subunit
FT                                alpha, mitochondrial.
FT                                /FTId=PRO_0000020465.
FT   REGION      157    159       Thiamine pyrophosphate binding.
FT   METAL       206    206       Potassium.
FT   METAL       211    211       Potassium.
FT   METAL       212    212       Potassium.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     338    338       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     347    347       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     356    356       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     356    356       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   MOD_RES     380    380       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P50136}.
FT   VAR_SEQ      19     40       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056156.
FT   VAR_SEQ     331    331       Y -> YSSSPILPPDPHSREPTLTWGPLPLC (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056157.
FT   VARIANT      39     39       P -> H (in dbSNP:rs34589432).
FT                                /FTId=VAR_034360.
FT   VARIANT     151    151       T -> M (in dbSNP:rs34442879).
FT                                /FTId=VAR_034361.
FT   VARIANT     159    159       R -> W (in MSUD1A; dbSNP:rs769688327).
FT                                {ECO:0000269|PubMed:8161368}.
FT                                /FTId=VAR_004968.
FT   VARIANT     190    190       Q -> K (in MSUD1A).
FT                                {ECO:0000269|PubMed:8161368}.
FT                                /FTId=VAR_004969.
FT   VARIANT     211    211       T -> M (in MSUD1A; dbSNP:rs398123503).
FT                                {ECO:0000269|PubMed:21844576}.
FT                                /FTId=VAR_069748.
FT   VARIANT     220    220       A -> V (in MSUD1A; dbSNP:rs375785084).
FT                                {ECO:0000269|PubMed:21844576}.
FT                                /FTId=VAR_069749.
FT   VARIANT     253    253       A -> T (in MSUD1A; dbSNP:rs199599175).
FT                                {ECO:0000269|PubMed:8161368}.
FT                                /FTId=VAR_004970.
FT   VARIANT     290    290       G -> R (in MSUD1A; dbSNP:rs137852871).
FT                                {ECO:0000269|PubMed:7883996}.
FT                                /FTId=VAR_015101.
FT   VARIANT     326    326       I -> T (in MSUD1A).
FT                                {ECO:0000269|PubMed:8161368}.
FT                                /FTId=VAR_004971.
FT   VARIANT     346    346       R -> C (in MSUD1A; dbSNP:rs182923857).
FT                                {ECO:0000269|PubMed:21844576}.
FT                                /FTId=VAR_069750.
FT   VARIANT     403    403       P -> PKP (in MSUD1A).
FT                                /FTId=VAR_069751.
FT   VARIANT     409    409       F -> C (in MSUD1A; dbSNP:rs137852872).
FT                                {ECO:0000269|PubMed:7883996}.
FT                                /FTId=VAR_015102.
FT   VARIANT     413    413       Y -> C (in MSUD1A).
FT                                {ECO:0000269|PubMed:8037208}.
FT                                /FTId=VAR_004972.
FT   VARIANT     427    428       LA -> P (in MSUD1A).
FT                                {ECO:0000269|PubMed:21844576}.
FT                                /FTId=VAR_069752.
FT   VARIANT     438    438       Y -> N (in MSUD1A; impedes assembly of
FT                                the E1 component; dbSNP:rs137852870).
FT                                {ECO:0000269|PubMed:1867199,
FT                                ECO:0000269|PubMed:1885764,
FT                                ECO:0000269|PubMed:2060625,
FT                                ECO:0000269|PubMed:2241958,
FT                                ECO:0000269|PubMed:2703538}.
FT                                /FTId=VAR_004973.
FT   CONFLICT      3      3       V -> G (in Ref. 6; AAB20222/AAB19268).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       S -> A (in Ref. 5; AAB59549).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       A -> D (in Ref. 8; AAA35590).
FT                                {ECO:0000305}.
FT   STRAND       61     64       {ECO:0000244|PDB:2J9F}.
FT   STRAND       88     90       {ECO:0000244|PDB:1DTW}.
FT   HELIX        91     93       {ECO:0000244|PDB:2BFD}.
FT   HELIX        99    124       {ECO:0000244|PDB:2BFD}.
FT   STRAND      127    129       {ECO:0000244|PDB:2BFD}.
FT   TURN        135    137       {ECO:0000244|PDB:2BFB}.
FT   HELIX       138    146       {ECO:0000244|PDB:2BFD}.
FT   STRAND      152    155       {ECO:0000244|PDB:2BFD}.
FT   HELIX       161    166       {ECO:0000244|PDB:2BFD}.
FT   HELIX       171    179       {ECO:0000244|PDB:2BFD}.
FT   TURN        185    188       {ECO:0000244|PDB:2BFD}.
FT   TURN        198    201       {ECO:0000244|PDB:2BFD}.
FT   TURN        209    211       {ECO:0000244|PDB:2BFD}.
FT   HELIX       212    226       {ECO:0000244|PDB:2BFD}.
FT   STRAND      232    237       {ECO:0000244|PDB:2BFD}.
FT   HELIX       240    242       {ECO:0000244|PDB:2BFD}.
FT   HELIX       244    255       {ECO:0000244|PDB:2BFD}.
FT   STRAND      260    266       {ECO:0000244|PDB:2BFD}.
FT   STRAND      268    270       {ECO:0000244|PDB:2BFD}.
FT   HELIX       275    277       {ECO:0000244|PDB:2BFD}.
FT   STRAND      280    282       {ECO:0000244|PDB:2BFD}.
FT   HELIX       285    287       {ECO:0000244|PDB:2BFD}.
FT   HELIX       289    291       {ECO:0000244|PDB:2BFD}.
FT   STRAND      294    299       {ECO:0000244|PDB:2BFD}.
FT   HELIX       303    320       {ECO:0000244|PDB:2BFD}.
FT   STRAND      324    329       {ECO:0000244|PDB:2BFD}.
FT   HELIX       342    344       {ECO:0000244|PDB:2BFF}.
FT   HELIX       351    357       {ECO:0000244|PDB:2BFF}.
FT   HELIX       360    368       {ECO:0000244|PDB:2BFD}.
FT   TURN        369    372       {ECO:0000244|PDB:2BFD}.
FT   HELIX       376    399       {ECO:0000244|PDB:2BFD}.
FT   HELIX       405    408       {ECO:0000244|PDB:2BFD}.
FT   TURN        409    411       {ECO:0000244|PDB:2BEW}.
FT   STRAND      412    415       {ECO:0000244|PDB:2BFD}.
FT   HELIX       418    434       {ECO:0000244|PDB:2BFD}.
FT   HELIX       435    437       {ECO:0000244|PDB:2BFD}.
FT   HELIX       440    442       {ECO:0000244|PDB:2BFD}.
SQ   SEQUENCE   445 AA;  50471 MW;  2B4DD658924DB0C3 CRC64;
     MAVAIAAARV WRLNRGLSQA ALLLLRQPGA RGLARSHPPR QQQQFSSLDD KPQFPGASAE
     FIDKLEFIQP NVISGIPIYR VMDRQGQIIN PSEDPHLPKE KVLKLYKSMT LLNTMDRILY
     ESQRQGRISF YMTNYGEEGT HVGSAAALDN TDLVFGQYRE AGVLMYRDYP LELFMAQCYG
     NISDLGKGRQ MPVHYGCKER HFVTISSPLA TQIPQAVGAA YAAKRANANR VVICYFGEGA
     ASEGDAHAGF NFAATLECPI IFFCRNNGYA ISTPTSEQYR GDGIAARGPG YGIMSIRVDG
     NDVFAVYNAT KEARRRAVAE NQPFLIEAMT YRIGHHSTSD DSSAYRSVDE VNYWDKQDHP
     ISRLRHYLLS QGWWDEEQEK AWRKQSRRKV MEAFEQAERK PKPNPNLLFS DVYQEMPAQL
     RKQQESLARH LQTYGEHYPL DHFDK
//
